Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial.

Autor: Ana Claudia Souza Palmer, Maxciel Zortea, Andressa Souza, Vinicius Santos, Jorge Villanova Biazús, Iraci L S Torres, Felipe Fregni, Wolnei Caumo

Publikováno v: PLoS ONE, Vol 15, Iss 4, p e0231379 (2020)

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer (ACBC) reduced the side effects associated with cognitive impairment.

Externí odkaz: https://doaj.org/article/2bfaf64d83f74b99a7ab7075d8497184

Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial

Autor: Wolnei Caumo, Jorge Villanova Biazús, Felipe Fregni, Ana Claudia Souza Palmer, Iraci Lucena da Silva Torres, Andressa de Souza, Maxciel Zortea, Vinícius Souza dos Santos

Publikováno v: PLoS ONE
Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
PLoS ONE, Vol 15, Iss 4, p e0231379 (2020)

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer (ACBC) reduced the side effects associated with cognitive impairment.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe640a81569f5c9ccc8471cf868bb10
https://doi.org/10.1371/journal.pone.0231379